iData Research reports Medtronic and NuVasive are leading the U.S. minimally invasive spine implant market.
"Growth in the minimally invasive spinal implant market is largely driven by the advantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower postoperative medication and earlier return to work," said Jeffrey Wong, a strategic analyst manager at iData Research. "However, growth is expected to slow as a result of the increasing penetration of MIS procedures into the traditional fusion market and growing motion preservation market."
The key trends in the report include:
1. A shift toward oblique lumbar interbody fusion and lateral lumbar interbody fusion while the market moves away from minimally invasive posterior lumbar interbody fusion and transforaminal lumbar interbody fusion devices.
2. SI-Bone's iFuse Implant System is the fastest growing implant segment in the minimally invasive sacroiliac joint fusion market, which has grown rapidly since reimbursement policy changed for the procedure. The market is expected to stabilize in the coming years.
3. NuVasive leads the U.S. minimally invasive spine market in the interbody device, pedicle screw, spinous process fixation and facet fixation segments.
4. Medtronic is the second leading company in the minimally invasive spine device market driven by the minimal access spine technology systems including METRx and CD Horizon systems. The company's spinal products also include minimally invasive non-fusion procedures like X-Stop and Kyphon.
5. The other major competitors in the market are DePuy Synthes, Globus Medical, Stryker, K2M and Richard Wolf.